Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-24 @ 6:51 PM
NCT ID:
NCT02911857
Eligibility Criteria:
Inclusion Criteria:
* Completed Epoch 4 of the CACZ885N2301 study in Japan before the approval of canakinumab in Japan
* Written informed consent. Parent or legal guardian's written informed consent and child's assent, if appropriate, are required before any assessment is performed for patients \< 20 years of age
Exclusion Criteria:
* Any conditions or significant medical problems in which the investigator judges the patient should not enter this extension study
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02911857
Study Brief:
Protocol Section:
NCT02911857